Drug intelligence / Profile preview

tannic acid protein yeast powder

Development stage
Unknown
Lead developer
Ginwa Enterprise Group
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Tannic acid protein yeast powder is an oral combination drug product used for the treatment of diarrhea in children, particularly that caused by enteritis or indigestion. [24, 29] The product is manufactured by several companies, including Jinhua Enterprise. [22] Upon oral administration, the tannic acid protein component is broken down by intestinal enzymes, which slowly releases tannic acid. [17, 22] The tannic acid acts as an astringent by precipitating proteins on the surface of the intestinal mucosa. This forms a protective film that reduces irritation, decreases inflammatory secretions, and lessens intestinal peristalsis, thereby providing an antidiarrheal effect. [17, 21, 22] The second component, dry yeast (from brewer's yeast), is rich in B vitamins and provides an auxiliary therapeutic benefit for associated indigestion. [17, 22] The formulation is approved and available as an over-the-counter powder. [22]

Other names
鞣酸蛋白酵母散Albumin Tannate and Barm Powder
02

Targets

RBD (SARS-CoV-2 spike receptor-binding domain)

Beyond the preview

Go deeper on tannic acid protein yeast powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tannic acid protein yeast powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call